YI04 - Recruitment of stem cell populations to the lung with disease

K. Gowers (London, United Kingdom)

Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Number: 15

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Gowers (London, United Kingdom). YI04 - Recruitment of stem cell populations to the lung with disease. Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017



LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


In search of ckit+ stem cells in lung tissue
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021



Lung stem cells and the role of the stem cell niche
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021


Single cell analysis of human lung development: knowing what mesenchymal cells are and what they may be
Source: Eur Respir J, 55 (1) 1902327; 10.1183/13993003.02327-2019
Year: 2020



Circulating CD133(+) stem cells in lung cancer patients
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Identification and characterization of mesenchymal stem cells in the human lung
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Stem cells, their niches, and evolving concepts concerning cancer
Source: Annual Congress 2007 - Stem cells and the lung: the road from basics to clinics
Year: 2007


Lung stem cells and lung cancer
Source: ERS Lung Science Conference 2017
Year: 2017

Clinical implication of stem cell markers in N2 positive non-small cell lung cancer
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012


Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021


Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Mesenchymal lineage formation in the lung during development and disease
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

Discrimination of expanded dendritic cell populations in lung tissues from COPD patients
Source: Annual Congress 2011 - Novel mechanisms in COPD
Year: 2011

Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021